Skip to Content

Notice

Manufacturer of Controlled Substances; Notice of Registration

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

By Notice dated August 19, 2003, and published in the Federal Register on September 2, 2003, (68 FR 52225), LinZhi International, Inc., 687 North Pastoria Avenue, Sunnyvale, California 94085, made application to the Drug Enforcement Administration for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

DrugSchedule
Tetrahydrocannabinols (7370)I
3,4-Methylenedioxymethamphetamine (7405)I
Amphetamine (1100)II
Methamphetamine (1105)II
Secobarbital (2315)II
Phencyclidine (7471)II
Cocaine (9041)II
Methadone (9250)II
Dextropropoxyphene (9273)II
Morphine (9300)II

The firm plans to manufacture small quantities of controlled substances to make drug testing reagents and controls.

No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of LinZhi International, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated Lin-Zhi International, Inc. to ensure that the company's registration is consistent with the public interest. This investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as bulk manufacturer of the basic classes of controlled substances listed is granted.

Start Signature

Dated: November 19, 2003.

Laura M. Nagel,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 03-29975 Filed 12-1-03; 8:45 am]

BILLING CODE 4410-09-M